{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:29:37Z","timestamp":1780536577334,"version":"3.54.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2023,7,18]]},"abstract":"<jats:p>\n            We conducted\n            <jats:italic>in vitro<\/jats:italic>\n            antimicrobial susceptibility testing of 267\n            <jats:italic>Achromobacter<\/jats:italic>\n            isolates for 16 antibiotics from 2017 to 2022. The highest susceptibility was found for piperacillin-tazobactam (70%) and ceftazidime-avibactam (62%).\n          <\/jats:p>","DOI":"10.1128\/aac.00379-23","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T14:01:28Z","timestamp":1686664888000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["<i>In Vitro<\/i>\n            Susceptibility of\n            <i>Achromobacter<\/i>\n            Species Isolated from Cystic Fibrosis Patients: a 6-Year Survey"],"prefix":"10.1128","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-9951","authenticated-orcid":true,"given":"Margo","family":"Olbrecht","sequence":"first","affiliation":[{"name":"Department Microbiology and Infection Control, National Reference Center for Burkholderia Cepacia Complex and other Gram negative non fermenters (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedoua","family":"Echahidi","sequence":"additional","affiliation":[{"name":"Department Microbiology and Infection Control, National Reference Center for Burkholderia Cepacia Complex and other Gram negative non fermenters (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Pi\u00e9rard","sequence":"additional","affiliation":[{"name":"Department Microbiology and Infection Control, National Reference Center for Burkholderia Cepacia Complex and other Gram negative non fermenters (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1891-4869","authenticated-orcid":true,"given":"Charlotte","family":"Peeters","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vandamme","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6217-1695","authenticated-orcid":true,"given":"Ingrid","family":"Wybo","sequence":"additional","affiliation":[{"name":"Department Microbiology and Infection Control, National Reference Center for Burkholderia Cepacia Complex and other Gram negative non fermenters (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Demuyser","sequence":"additional","affiliation":[{"name":"Department Microbiology and Infection Control, National Reference Center for Burkholderia Cepacia Complex and other Gram negative non fermenters (NRC), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium"},{"name":"AIMS lab, Center for Neurosciences, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817381.ch45"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.10.002"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.03.012"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2009.12.007"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01078"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.52586\/5054"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01025-20"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.04.013"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201701-071OC"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.08.005"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1412"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.08.014"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000582"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02911-20"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04260-14"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evx061"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00341-11"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01243-12"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.12.3322-3327.2000"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00590-18"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.485979"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0168-2"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02688-16"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02291-19"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S40698"},{"key":"e_1_3_1_27_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2020. Achromobacter xylosoxidans \u2013 proposed clinical breakpoints."},{"key":"e_1_3_1_28_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2023. Breakpoint tables for interpretation of MICs and zone diameters version 13.0."},{"key":"e_1_3_1_29_2","unstructured":"Clinical and Laboratory Standards Institute (CLSI). 2022. EM100 Connect - CLSI M100 ED32:2022. http:\/\/em100.edaptivedocs.net\/GetDoc.aspx?doc=CLSI%20M100%20ED32:2022&sbssok=CLSI%20M100%20ED32:2022%20TABLE%202B-5&format=HTML&hl=non-enterobacterales. Retrieved 2 February 2023."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00814-12"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14826.1"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02148656"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ram.2019.03.004"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000499"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.09.005"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00494-13"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.12.009"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2447"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01595-19"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00379-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00379-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:04:13Z","timestamp":1689685453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00379-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,18]]}},"alternative-id":["10.1128\/aac.00379-23"],"URL":"https:\/\/doi.org\/10.1128\/aac.00379-23","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"2023-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00379-23"}}